Home » Topics » Regulatory

Regulatory
RSS

ODAC recommends approval of another new indication for Taxol

Sep. 20, 1999

FDA approves Rapamune for rejection prevention in renal transplantation

Sep. 17, 1999

Novo Nordisk's liquid growth hormone approved in the E.U.

Sep. 17, 1999

Colazide approved for ulcerative colitis maintenance in Europe

Sep. 17, 1999

NovoRapid approved in E.U. for treatment of diabetes

Sep. 10, 1999

Fujisawa seeks approval for tacrolimus ointment in the U.S.

Sep. 10, 1999

FDA approves new indications for Zerit and Videx

Sep. 9, 1999

New ulcer drug approved for the first time in Japan

Sep. 1, 1999

Eisai's proton pump inhibitor approved in E.U. for GERD maintenance

Sep. 1, 1999

Celecoxib NDA receives priority review designation for FAP

Aug. 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.